Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGRC.L Regulatory News (GRC)

  • There is currently no data for GRC

Director/PDMR Shareholding

5 Feb 2021 07:00

RNS Number : 0864O
GRC International Group PLC
05 February 2021
 

5 February 2021

 

 

GRC International Group plc

Director Dealing

GRC International Group plc (AIM: GRC) (the "Company") today announces that Steve Watkins, a director of the Company, has sold 815,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") in the market, at a value of 21 pence per share.

Following this sale of shares, Steve Watkins retains a beneficial interest over 3,727,082 Ordinary Shares, representing 3.73% of the current total voting rights of the Company.

Further details on the transfer are included in the notification below, made in accordance with the requirements of the EU Market Abuse Regulation.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries

GRC International Group plc

Alan Calder (CEO)

Chris Hartshorne (Finance Director)

 

 

www.grci.group

033 3800 7000

Grant Thornton UK LLP (Nomad)

Philip Secrett / Jamie Barklem / Seamus Fricker

 

 

020 7383 5100

Dowgate Capital Limited (Broker)

James Serjeant

020 3903 7715

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve Watkins

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

GRC International Group plc

b)

 

LEI

 

 

21380035NES3I6H4PB87

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

Identification code

GB00BG06MV41

b)

 

Nature of the transaction

 

 

Sale of shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

£0.21

815,000

d)

 

Aggregated information

- Aggregated volume

N/A

- Price

e)

 

Date of the transaction

 

 

04 February 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLZLLBFLLEBBD
Date   Source Headline
3rd May 20227:00 amRNSTrading Update
31st Jan 20227:00 amRNSTotal Voting Rights
26th Jan 20226:15 pmRNSHolding(s) in Company
25th Jan 20224:08 pmRNSHolding(s) in Company
18th Jan 202212:31 pmRNSResults of Placing
17th Jan 20225:06 pmRNSProposed £3m fundraising
15th Dec 20211:02 pmRNSResult of AGM
14th Dec 20217:00 amRNSInterim Results
7th Dec 20217:00 amRNSSubscription Service Update
6th Dec 20213:28 pmRNSInvestor Presentation
1st Dec 20217:00 amRNSNotice of Results
19th Nov 20215:10 pmRNSAnnual General Meeting Notice
2nd Nov 20217:00 amRNSTrading Update
21st Oct 20215:36 pmRNSAnnual General Meeting
7th Sep 20217:00 amRNSPreliminary Results - Year Ended 31 March 2021
23rd Jun 20214:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20214:36 pmRNSPrice Monitoring Extension
23rd Jun 20212:06 pmRNSSecond Price Monitoring Extn
23rd Jun 20212:00 pmRNSPrice Monitoring Extension
13th May 20217:00 amRNSDirectorate Change
4th May 20217:00 amRNSTrading Update
23rd Mar 20212:48 pmRNSHolding(s) in Company
4th Mar 202111:10 amRNSPDMR Dealing
17th Feb 20217:00 amRNSDirectorate Change
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
11th Jan 20217:00 amRNSGDPR Privacy by Design focus for DQM GRC
29th Dec 20207:00 amRNSDirector/PDMR Shareholding
17th Dec 20207:00 amRNSInterim Results
26th Nov 20207:00 amRNSLaunch of services to help companies manage Brexit
9th Nov 20207:00 amRNSRelease of new Cyber Security as a Service product
3rd Nov 20207:00 amRNSGRCI Law releases new Privacy as a Service product
20th Oct 20204:23 pmRNSResult of AGM
1st Oct 20207:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
21st Sep 20207:00 amRNSPreliminary Results - Year Ended 31 March 2020
16th Sep 20207:00 amRNSNotice of Results
22nd Jun 202010:03 amRNSTrading Update - Replacement
22nd Jun 20207:00 amRNSTrading Update
11th May 202011:00 amRNSHolding(s) in Company
20th Apr 202010:23 amRNSHolding(s) in Company
2nd Apr 20207:00 amRNSCOVID-19 Response
20th Feb 202010:15 amRNSHolding(s) in Company
20th Feb 20208:30 amRNSDirector/PDMR Shareholding
18th Feb 202011:43 amRNSResult of General Meeting, Director Dealing, TVR
3rd Feb 20202:03 pmRNSExercise of Options, Director Dealing and TVR
31st Jan 202011:45 amRNSDQM Update, Placing and Notice of General Meeting
18th Dec 20197:00 amRNSInterim Results
29th Oct 201912:01 pmRNSResult of Annual General Meeting
26th Sep 20197:00 amRNSFinal results for the year ended 31 March 2019
22nd Jul 20197:00 amRNSPostponement of Preliminary Results
16th Jul 201912:39 pmRNSNotice of Results and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.